These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37014177)

  • 1. Targeted delivery of epirubicin to breast cancer cells using poly-aptamer DNA nanocarriers prepared by the RCA method with multiple repeats of aptamers of FOXM1 and AS1411.
    Moradi E; Zavvar T; Alibolandi M; Ramezani M; Abnous K; Taghdisi SM
    Drug Dev Ind Pharm; 2023 Mar; 49(3):260-270. PubMed ID: 37014177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
    Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeted delivery system using hollow silica nanoparticles with H
    Mirzaei S; Khademi Z; Zolfaghari R; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Drug Dev Ind Pharm; 2023 Oct; 49(10):648-657. PubMed ID: 37772892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
    Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
    Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Delivery of Epirubicin to Cancer Cells by Polyvalent Aptamer System in vitro and in vivo.
    Yazdian-Robati R; Ramezani M; Jalalian SH; Abnous K; Taghdisi SM
    Pharm Res; 2016 Sep; 33(9):2289-97. PubMed ID: 27283831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
    Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model.
    Zavvar T; Babaei M; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
    Int J Pharm; 2020 Mar; 578():119091. PubMed ID: 32007591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
    Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
    Yaghoobi E; Zavvar T; Ramezani M; Alibolandi M; Rahimzadeh Oskuei S; Zahiri M; Alinezhad Nameghi M; Abnous K; Taghdisi SM
    J Drug Target; 2022 Dec; 30(10):1106-1112. PubMed ID: 35736221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo.
    Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM
    Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of epirubicin to cancerous cell using copper sulphide nanoparticle coated with polyarginine and 5TR1 aptamer.
    Alizadeh F; Yaghoobi E; Imanimoghadam M; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    J Drug Target; 2023 Dec; 31(9):986-997. PubMed ID: 37869893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
    Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
    Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
    Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
    Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo.
    Jalalian SH; Ramezani M; Abnous K; Taghdisi SM
    Cancer Lett; 2018 Mar; 416():87-93. PubMed ID: 29253524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma.
    Abrishami A; Bahrami AR; Saljooghi AS; Matin MM
    Nanoscale; 2024 Mar; 16(12):6215-6240. PubMed ID: 38446130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor.
    Shakib Z; Mahmoudi A; Moosavian SA; Malaekeh-Nikouei B
    Drug Dev Ind Pharm; 2022 Feb; 48(2):69-78. PubMed ID: 35758194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.